Advertisement

Topics

Triumvira Expands Management Team with Chief Medical Officer and VP of Finance

09:02 EDT 17 May 2018 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Innovative immuno-therapy company welcomes proven leaders in pharma and therapeutics Triumvira Immunologics, a privately held biopharmaceutical company developing a novel platform for engineering T cells to attack can...

Other Sources for this Article

LaVoieHealthScience
Beth Kurth, +1 617-374-8800, Ext. 106
Vice President, Investor Relations & Corporate Communications
bkurth@lavoiehealthscience.com

NEXT ARTICLE

More From BioPortfolio on "Triumvira Expands Management Team with Chief Medical Officer and VP of Finance"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...